% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{vandeBurgt:280223,
author = {van de Burgt, Nikita A and Kulsvehagen, Laila and
Mané-Damas, Marina and Lutz, Luc and Lecourt,
Anne-Catherine and Monserrat, Clara and Vinke, Anita M and
Küçükali, Cem I and Zong, Shenghua and Hoffmann, Carolin
and González-Vioque, Emiliano and Arango, Celso and
Leibold, Nicole K and Losen, Mario and Molenaar, Peter C and
Tüzün, Erdem and van Beveren, Nico J M and Mané, Anna and
Rouhl, Rob P W and van Amelsvoort, Therese A M J and Risk,
for Genetic and Pröbstel, Anne-Katrin and
Martinez-Martinez, Pilar},
collaboration = {Psychosis, Outcome of},
title = {{A}utoantibodies against myelin oligodendrocyte
glycoprotein in a subgroup of patients with psychotic
symptoms.},
journal = {Frontiers in neurology},
volume = {16},
issn = {1664-2295},
address = {Lausanne},
publisher = {Frontiers Research Foundation},
reportid = {DZNE-2025-00901},
pages = {1593042},
year = {2025},
abstract = {The presence of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG) is a hallmark of MOG
antibody-associated disease (MOGAD), a recently defined
demyelinating disease entity presenting with core clinical
features of optic neuritis, myelitis, and acute disseminated
encephalomyelitis. Although MOG antibodies have also been
described in a small number of patients with other
conditions, including mental disorders, their prevalence and
clinical specificity in patients with isolated psychotic
symptoms remain unclear. Here, we screened sera from 262
patients with at least one psychotic episode and 166 control
subjects for the presence of MOG antibodies of the
immunoglobulin G (IgG) isotype with a live cell-based assay.
Serum reactivity to additional antigens was assessed by
immunohistochemistry. Four patients, representing $1.5\%$ of
the patient cohort, and one control individual,
representing. $0.6\%$ of the healthy control cohort, were
seropositive for MOG-IgG antibodies. Of the four MOG-IgG
seropositive patients, three experienced visual
hallucinations. Overall, MOG antibodies were detected at a
low frequency in patients with psychotic episodes. While we
cannot exclude the possibility of false-positive results or
seroconversion due to secondary myelin damage, the
association with visual hallucinations in three out of four
MOG-IgG seropositive patients may point toward an underlying
autoimmune etiology.},
keywords = {autoantibodies (Other) / mental disorders (Other) / myelin
oligodendrocyte glycoprotein antibody-associated disease
(Other) / neuroinflammation (Other) / psychiatry (Other) /
psychosis (Other)},
cin = {AG Pröbstel},
ddc = {610},
cid = {I:(DE-2719)1013045},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40757033},
pmc = {pmc:PMC12316182},
doi = {10.3389/fneur.2025.1593042},
url = {https://pub.dzne.de/record/280223},
}